Delivery Order SPE2DB20D2104-SPE2DB24FQ71D
Award Date 10/12/23
Potential Completion Date 10/13/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,679.34 firm fixed-price delivery order is for the supply of ESTROGEL 0.06% GEL 37.5GM, a pharmaceutical product. The contract has a completion date of May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $5,212.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen...
- This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the product "ESTROGEL 0.06% GEL 37.5GM" with a ceiling value of $3,331.54 and a completion date of November 7, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award with ID SPE2DB24D1007|SPE2DB25FBZNX was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.22 firm fixed price delivery order is for the medical product ESTROGEL 0.06% GEL 37.5GM. This award is not designated under any set-aside program. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. AmerisourceBergen holds a...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation. The $3,253.76 firm fixed price delivery order is for the supply of ESTROGEL 0.06% GEL 50GM, a pharmaceutical product, with a completion date of January 9, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. As a key supplier of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,257.58 firm fixed-price delivery order is for the supply of 1,000 units of the pharmaceutical product ESTROGENS.625MG. The contract has an ultimate completion date of July 31, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency issued a $1,963.89 delivery order to AmerisourceBergen Drug Corp on April 9, 2026, for Estrogel 0.06% gel 37.5GM pharmaceutical supply. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that enables supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. Ultimate completion date is...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Estradiol 0.06% 1.25g gel pump. The award, valued at $1,193.22, is a firm fixed-price delivery order contract with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-five thousand eight hundred four dollars to Amerisourcebergen Drug Corporation for ESTROGEL 0.06% gel in 50 gram containers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 28 and July 31, 2023. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract vehicle, Amerisourcebergen will deliver the prescribed estrogen gel to support the...
- <p>Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $623.36 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 50 grams of Estrogel 0.06% gel. The single day contract has a period of performance from August 31, 2023 through September 1, 2023. No subcontractors or additional context were provided. DLA Troop Support Medical supports the medical supply needs of the Department of Defense.</p>